0001140361-24-032163.txt : 20240702
0001140361-24-032163.hdr.sgml : 20240702
20240702163042
ACCESSION NUMBER: 0001140361-24-032163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GKCC, LLC
CENTRAL INDEX KEY: 0001977769
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 241096038
BUSINESS ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
BUSINESS PHONE: (302) 992-8882
MAIL ADDRESS:
STREET 1: 501 SILVERSIDE ROAD
STREET 2: SUITE 87AVA
CITY: WILMINGTON
STATE: DE
ZIP: 19809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chudnovsky Yekaterina
CENTRAL INDEX KEY: 0001979324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 241096039
MAIL ADDRESS:
STREET 1: C/O ELICIO THERAPEUTICS, INC.
STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
form4.xml
FORM 4
X0508
4
2024-06-28
0001601485
Elicio Therapeutics, Inc.
ELTX
0001979324
Chudnovsky Yekaterina
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR, SUITE 501
BOSTON
MA
02210
true
true
0001977769
GKCC, LLC
501 SILVERSIDE ROAD
SUITE 87AVA
WILMINGTON
DE
19809
true
false
Common Warrants
5
2024-06-28
4
P
0
1600000
0
A
Common Stock
1600000
1600000
D
Pre-Funded Warrants
0.01
2024-06-28
4
P
0
1600000
4.99
A
Common Stock
1600000
1600000
D
Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
The Common Warrants expire on July 1, 2029.
Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
The Pre-Funded Warrants do not have an expiration date.
/s/ Yekaterina Chudnovsky
2024-07-02
/s/ Yekaterina Chudnovsky, Manager GKCC, LLC
2024-07-02